Vinay Rasita, Baumann Holger, Biller-Andorno Nikola
Institute of Biomedical Ethics and History of Medicine, Faculty of Medicine, University of Zurich, Winterthurerstrasse 30, 8006 Zurich, Switzerland.
Department of Philosophy, Zollikerstrasse 117, 8008 Zurich, Switzerland.
Br Med Bull. 2021 Jun 10;138(1):5-15. doi: 10.1093/bmb/ldab009.
The coronavirus disease 2019 pandemic has placed intensive care units (ICU) triage at the center of bioethical discussions. National and international triage guidelines emerged from professional and governmental bodies and have led to controversial discussions about which criteria-e.g. medical prognosis, age, life-expectancy or quality of life-are ethically acceptable. The paper presents the main points of agreement and disagreement in triage protocols and reviews the ethical debate surrounding them.
Published articles, news articles, book chapters, ICU triage guidelines set out by professional societies and health authorities.
Points of agreement in the guidelines that are widely supported by ethical arguments are (i) to avoid using a first come, first served policy or quality-adjusted life-years and (ii) to rely on medical prognosis, maximizing lives saved, justice as fairness and non-discrimination.
Points of disagreement in existing guidelines and the ethics literature more broadly regard the use of exclusion criteria, the role of life expectancy, the prioritization of healthcare workers and the reassessment of triage decisions.
Improve outcome predictions, possibly aided by Artificial intelligence (AI); develop participatory approaches to drafting, assessing and revising triaging protocols; learn from experiences with implementation of guidelines with a view to continuously improve decision-making.
Examine the universality vs. context-dependence of triaging principles and criteria; empirically test the appropriateness of triaging guidelines, including impact on vulnerable groups and risk of discrimination; study the potential and challenges of AI for outcome and preference prediction and decision-support.
2019年冠状病毒病大流行使重症监护病房(ICU)分诊成为生物伦理讨论的核心。国家和国际分诊指南由专业和政府机构制定,引发了关于哪些标准(如医学预后、年龄、预期寿命或生活质量)在伦理上可接受的争议性讨论。本文介绍了分诊协议中的主要共识和分歧点,并回顾了围绕这些协议的伦理辩论。
已发表的文章、新闻报道、书籍章节、专业协会和卫生当局制定的ICU分诊指南。
指南中得到伦理论据广泛支持的共识点包括:(i)避免采用先到先得政策或质量调整生命年;(ii)依靠医学预后,最大限度地挽救生命,秉持公平即正义和不歧视原则。
现有指南和更广泛的伦理文献中的分歧点主要涉及排除标准的使用、预期寿命的作用、医护人员的优先排序以及分诊决策的重新评估。
改进预后预测,可能借助人工智能(AI)的帮助;制定参与式方法来起草、评估和修订分诊协议;借鉴指南实施经验以不断改进决策。
研究分诊原则和标准的普遍性与情境依赖性;实证检验分诊指南的适当性,包括对弱势群体的影响和歧视风险;研究人工智能在预后和偏好预测及决策支持方面的潜力和挑战。